Skin and Connective Tissue Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: .1-Patients aged 18-50 years presented with atrophic post-acne scars. 2-Patients who will accept to be included in the study, and will sign a written consent. 3-Patients agreed to participate after full explanation of the procedure
Exclusion criteria
Exclusion criteria: 1-Patients who have any hypersensitivity reactions to BTX-A or autologous stem cells or amniotic collagen matrix or any material used in the study. 2-Pregnant and lactating women. .3-Patients with active inflammatory acne or active infection in the treatment area. 4-Patients with premalignant or malignant lesions in the treatment area. 5-Patients with photosensitive dermatoses. 6-Patients with a history of chronic diseases (liver or kidney diseases). 7-Patients with coagulation defects and blood diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| evaluation the efficacy and safety of micro-needling alone versus micro-needling combined with BTX-A, or combined with Autologous Cell Micro-graft, or combined with irradiated amniotic collagen matrix in the treatment of Atrophic Post-Acne Scars. | — |
Secondary
| Measure | Time frame |
|---|---|
| evaluation effect in degree of patient satisfaction | — |
Countries
Egypt
Contacts
doctor